Recall issued for several own label glycerine and blackcurrant cough syrups

Recall issued for several own label glycerine and blackcurrant cough syrups

June 20 2018 A Class 2 Drug Recall has been issued for 15 batches of own-brand children’s...

Bath emollients have ‘no benefit beyond standard eczema care for children’

Bath emollients have ‘no benefit beyond standard eczema care for children’

May 9 2018 A study has found no evidence of clinical benefit from including bath emollients in...

Cochrane: honey rated better for children’s cough than some OTC preps or placebo

Cochrane: honey rated better for children’s cough than some OTC preps or placebo

April 16 2018 Honey appears likely to help children’s cough more than diphenhydramine, a...

OTC Viagra Connect availability to widen following launch via Boots

OTC Viagra Connect availability to widen following launch via Boots

April 11 2018 Viagra Connect should be available from most pharmacies at the end of this week,...

MHRA issues warning over flammability of headlice treatments

MHRA issues warning over flammability of headlice treatments

March 9 2018 Pharmacists have been asked to tell customers about the risk of fire when discussing...

  • Recall issued for several own label glycerine and blackcurrant cough syrups

    Recall issued for several own label glycerine and blackcurrant cough syrups

    Wednesday, 20 June 2018 18:29
  • Bath emollients have ‘no benefit beyond standard eczema care for children’

    Bath emollients have ‘no benefit beyond standard eczema care for children’

    Wednesday, 09 May 2018 15:28
  • Cochrane: honey rated better for children’s cough than some OTC preps or placebo

    Cochrane: honey rated better for children’s cough than some OTC preps or placebo

    Monday, 16 April 2018 09:13
  • OTC Viagra Connect availability to widen following launch via Boots

    OTC Viagra Connect availability to widen following launch via Boots

    Wednesday, 11 April 2018 12:52
  • MHRA issues warning over flammability of headlice treatments

    MHRA issues warning over flammability of headlice treatments

    Friday, 09 March 2018 16:15

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

supplementsJune 20 2016

Consumers’ association Which? has challenged dietary supplement products which suggest they can help improve brain health. In particular, they have raised concerns that products are suggesting they can help reduce the risk of dementia.

The Which? panel of experts including a dietitian, a GP and a professor of public health medicines, have looked at a number of services and products. They concluded that “there is no robust evidence that the vitamins, plant extracts and other ‘functional’ ingredients commonly used in these supplements can reduce the risk of dementia.”

Which? has reported one product’s claims to the Advertising Standards Authority, and has said the panel was also sceptical of online and in person tests and investigations that try to spot mild cognitive impairment. It says people using these may have to pay more than £1,000.

Its review of products of products to avoid highlights four supplements and one app, saying the experts “do not believe the science doesn’t stack up.” Ingredients attributed to any brain function improvement but challenged by the panel included omega-3 fatty acids such as docosahexaenoic acid (DHA) at higher concentrations, Ginkgo biloba, B vitamins, and N-acetylcysteine.

“It’s unacceptable that some companies are preying on people’s fears, making claims they simply can’t back up,” said Which? Director of Policy and Campaigns Alex Neill. “For people worried about dementia our advice is you don’t need to spend time and money on expensive supplements or products, like online tests or apps. There are many alternative sources of free, independent information and advice that can help you to understand your options and next steps.”

Links:

Which? announcement

Which? opinion

OTC News

June 22 2018 A review into the scheduling of cannabis for medicinal purposes will look for “significant medical and therapeutic benefits” before a decision is made.
June 19 2018 A practice-based audit will seek to explore community pharmacy’s contribution in supporting girls and women of childbearing potential who need to take valproate medicines. Launched by...